Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma
Clinical trial NCT03811886 · WITHDRAWN
Trial details
- NCT number
- NCT03811886
- Sponsor
- Case Comprehensive Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.